MSE Pharmazeutika

MSE Pharmazeutika is a German pharmaceutical company specializing in mitochondrial medicine and the development of high-quality nutritional supplements and therapeutic compounds. Founded by Dr. Franz Enzmann, a pioneer in Coenzyme Q10 research, the company focuses on substances that support cellular energy production and combat oxidative stress. Their product portfolio includes various formulations of ubiquinone (Q10), vitamins, and minerals designed to address mitochondrial deficiencies and metabolic disorders. MSE Pharmazeutika operates primarily in the European market, providing evidence-based solutions for practitioners and patients focused on metabolic health. The company is recognized for its liquid Q10 formulations, which are designed for enhanced bioavailability.